Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Experts in cancer care have raised concern about the increasing intake of alcohol and tobacco use among young Nigerians, ...

Under the patronage of His Royal Highness Prince Salman bin Sultan bin Abdulaziz, Governor of Madinah Region, and in the ...

As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in cancer cells to help tumors grow.

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

I saw this as something that I thought would change me,” said Clark Gamblin, a cancer surgeon in Milwaukee. “And change me ...

Nurul Amni Sulha Che Mohammad, colorectal cancer patient. Her cancer is attributed to Lynch Syndrome, where a mutation in one of five specific genes that help repair DNA. causes her to be prone to ...

Bladder cancer is not the only cancer affected by the rule. Patients diagnosed with pancreatic, skin and thyroid cancers could lose access to genetic testing.

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.